Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
- Status
- COMPLETED
- Phase
- N/A
VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Disulfiram in Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Radiomics for Prediction of Survival in GBM
- Status
- COMPLETED
- Phase
- N/A
EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
- Status
- TERMINATED
- Phase
- PHASE1
TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2